| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/14/2004 | US20040204351 Soluble proteins that inhibit cytokine signal transduction pathways |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204349 Inducing cytotoxicity in a neoplastic cell comprising: contacting said cell with an amount of a GSSP-2 polypeptide |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203131 diagnosis of transmissible spongiform encephalopathies (TSEs) especially in an immunoassay, as well as its use as an immunogen; genetic engineering |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203117 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 10/14/2004 | US20040203116 IL-1 eta DNA and polypeptides |
| 10/14/2004 | US20040203115 Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
| 10/14/2004 | US20040203110 Novel human kielin-like proteins and polynucleotides encoding the same |
| 10/14/2004 | US20040203109 for drug screening anticancer agents; provides expression vectors, host cells, agonists, antibodies and antagonists; genetic engineering |
| 10/14/2004 | US20040203108 use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide |
| 10/14/2004 | US20040203106 Signal peptide-containing molecules |
| 10/14/2004 | US20040203102 Antiplasmin cleaving enzyme |
| 10/14/2004 | US20040203101 Brain-associated inhibitor of tissue-type plasminogen activator |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | US20040203093 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof |
| 10/14/2004 | US20040203091 Process for synthesizing protein using cell-free protein synthesis system |
| 10/14/2004 | US20040203084 protein antigens for producing neutralizing antibodies; biodrugs |
| 10/14/2004 | US20040203081 which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure |
| 10/14/2004 | US20040203080 7 transmembrane receptor family member BLRx |
| 10/14/2004 | US20040203073 Adenosine triphosphate (ATP)-binding cassette gene (ABC7), polypeptide and methods of detecting mutations therein; kits |
| 10/14/2004 | US20040203071 Biomolecular-based actuator |
| 10/14/2004 | US20040203066 Identifying modulator of progression elevated gene-3 (PEG-3) for use in treatment and prevention of antitumor/antiproliferative/antisense agents; peptide mimetic |
| 10/14/2004 | US20040203065 Novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 10/14/2004 | US20040203063 Comprises nucleotide sequence coding tumor marker protein for use in diagnosis of prostate cancer |
| 10/14/2004 | US20040203062 IGF-1 receptor interacting proteins |
| 10/14/2004 | US20040203053 Blackcurrant promoters and genes |
| 10/14/2004 | US20040203052 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 10/14/2004 | US20040203051 Nucleotide sequences coding two or more tumor associated antigens for use in identify modulators of major histocompatibility complex; preventing infections |
| 10/14/2004 | US20040203044 Promoting cardiac cell differentiation |
| 10/14/2004 | US20040203039 Attenuated salmonella SP12 mutants as antigen carriers |
| 10/14/2004 | US20040203033 Variant human alpha7 acetylcholine receptor subunit, and methods of production and use thereof |
| 10/14/2004 | US20040203027 Signal for targeting molecules to the sarco(endo)plasmic reticulum |
| 10/14/2004 | US20040203026 preferred cleaving conditions include heating in an acceptable buffer for a time ranging between about 16 and 24 hours at a temperature between about 20 degrees C. and about 37 degrees C |
| 10/14/2004 | US20040203022 clinical screening, diagnosis, prognosis, therapy and prophylaxis, as well as for drug screening and drug development using solid phase synthesis; kits |
| 10/14/2004 | US20040203020 Self-replicating RNA molecule from hepatitis C virus |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040203011 Fusion genes associated with acute megakaryoblastoc leukemias |
| 10/14/2004 | US20040203010 Compositions and methods for gender sorting |
| 10/14/2004 | US20040203009 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/14/2004 | US20040203006 Novel beta-tubulin protein of Candida glabrata and methods for its use |
| 10/14/2004 | US20040203003 comprising isolating messenger RNA and performing reverse transcription polymerase chain reaction (PCR) and assessing the concentrations of the resulting amplicons; genetic engineering |
| 10/14/2004 | US20040203001 Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof |
| 10/14/2004 | US20040202761 Cocoa flavor precursor peptides |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202678 attenuated, having a mutation in a gene encoding a repeat in toxin |
| 10/14/2004 | US20040202676 using aggregating, delipidating or oxidating agents or compounds enabling the release of lipids from the particles and their heterogeneous aggregation, wherein aggregates with particle sizes of between 30 and 500 nm are subsequently selected by means of a molecular exclusion process |
| 10/14/2004 | US20040202674 zona pellucida polypeptide, and/or a variant, from a carnivorous mammal, useful in reducing fertility of cats and/or dogs. |
| 10/14/2004 | US20040202673 designed to elicit high level of antibodies for immunotherapy or immunomodulation of the body regulatory processes. |
| 10/14/2004 | US20040202670 containing a biofilm peptide, especially a Haemophilus influenzae biofilm peptide, used to prevent otitis media |
| 10/14/2004 | US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins. |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202661 a peptide or derivative capable of binding to the IL-2 beta chain or the monoclonal antibodies produced by H2-8 hybridoma; induces SHC phosphorylation or induces the SHC/MAPK pathway |
| 10/14/2004 | US20040202654 gp100-derived polypeptides that contain both a helper T-cell epitope and a cytotoxic T-cell epitope used to induce antitumor responses in melanoma patients |
| 10/14/2004 | US20040202653 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 10/14/2004 | US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 10/14/2004 | US20040202648 Vaccines |
| 10/14/2004 | US20040202647 T cell line specific for a nitrotyrosine-containing compound; antibody specific for a self-antigen comprising a tyrosine to nitrotyrosine conversion; prevention and treatment of autoimmune diseases, infectious diseases and cancer through the recognition of compounds containing nitrated tyrosine residues |
| 10/14/2004 | US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/14/2004 | US20040202643 capable of change from insoluble and stable form to soluble and active form upon a change in temperature, pH, chemical composition, concentration, and/or change in shear force acting upon the crystal; capable of releasing their protein activity at a controlled rate |
| 10/14/2004 | US20040202642 E.g., treating or preventing Parkinson's disease or symptoms or associated physiology such as motor deficits or nigrostriatal degeneration inducing nigrostriatal regeneration; especially a vector that expresses GDNF |
| 10/14/2004 | US20040202641 Recombinant super-compound interferon |
| 10/14/2004 | DE10313636A1 Verwendung von Wirksubstanzen zur Vorbeuge oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen The use of active substances for the prevention or treatment of viral diseases and Test System for Finding such active substances |
| 10/14/2004 | DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4 |
| 10/14/2004 | CA2734606A1 Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production |
| 10/14/2004 | CA2521410A1 Inhibitor proteins of a protease and use thereof |
| 10/14/2004 | CA2521393A1 Peptabody for cancer treatment |
| 10/14/2004 | CA2521047A1 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 10/14/2004 | CA2520868A1 Staphylococcus epidermidis antigens |
| 10/14/2004 | CA2520861A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 10/14/2004 | CA2520671A1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 10/14/2004 | CA2520637A1 Mva virus expressing modified hiv envelope, gag, and pol genes |
| 10/14/2004 | CA2520386A1 Nontypeable haemophilus influenzae virulence factors |
| 10/14/2004 | CA2520382A1 Lupus antibodies for passive immunotherapy of hiv/aids |
| 10/14/2004 | CA2519803A1 Use of erythropoietin in stroke recovery |
| 10/13/2004 | EP1467207A1 Screening method |
| 10/13/2004 | EP1466978A1 Chitin oligosaccharide elicitor and gibberellin responsive genes in plant and utilization thereof |
| 10/13/2004 | EP1466976A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 10/13/2004 | EP1466975A1 Postsynaptic proteins |
| 10/13/2004 | EP1466974A1 Inducible site-directed mutagenesis through conditional gene rescue |
| 10/13/2004 | EP1466973A1 Characteristic base sequences occurring in plant genes and method of utilizing the same |
| 10/13/2004 | EP1466925A1 Antibodies against fibroblast growth factor 23 |
| 10/13/2004 | EP1466924A1 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 10/13/2004 | EP1466923A1 Method for producing lactoferrin |
| 10/13/2004 | EP1466888A1 Calcium receptor-active arylalkyl amines |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466619A2 Method for modulating cell apoptosis |
| 10/13/2004 | EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment |
| 10/13/2004 | EP1466614A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 10/13/2004 | EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 10/13/2004 | EP1466005A1 Carbohydrate-associated proteins |
| 10/13/2004 | EP1466001A2 Viruses with enhanced lytic potency medikament |
| 10/13/2004 | EP1465999A2 Fusion proteins |
| 10/13/2004 | EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |